Avalyn Pharma Inc. (AVLN)

CIK 1540171 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avalyn Pharma Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G0001388325-26-000044
Aug 12, 20268-K0001193125-26-345807
Aug 12, 202610-Q0001193125-26-345820
Aug 11, 2026SCHEDULE 13G0002149521-26-000002
Aug 6, 2026SCHEDULE 13G/A0000315066-26-002206
Jul 1, 20268-K0001193125-26-292834
Jun 17, 20268-K0001193125-26-273405
Jun 3, 202610-Q0001193125-26-254623
Jun 3, 20268-K0001193125-26-254581
May 8, 2026SCHEDULE 13D0000899140-26-000428
May 8, 2026SCHEDULE 13D0001072613-26-000386
May 7, 2026SCHEDULE 13G0001193125-26-212017
May 5, 2026SCHEDULE 13G0000315066-26-000743
May 5, 202640001193125-26-205201
May 5, 202640001388325-26-000021
May 4, 202640001193125-26-202381
May 1, 202640001193125-26-201887
May 1, 202640001193125-26-201894
May 1, 202640001193125-26-201863
May 1, 202640001193125-26-201856
May 1, 202640001193125-26-201860
May 1, 202640001193125-26-201865
May 1, 202640001193125-26-201867
May 1, 202640001193125-26-201868
May 1, 202640001193125-26-201870